Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

Renal cell tumors (RCTs) are the most lethal of the common urological cancers. The widespread use of imaging entailed an increased detection of small renal masses, emphasizing the need for accurate distinction between benign and malignant RCTs, which is critical for adequate therapeutic management....

Full description

Bibliographic Details
Main Author: Pires-Luís, Ana Sílvia (author)
Other Authors: Vieira-Coimbra, Marcia (author), Quintela Vieira, Ana Filipa (author), Costa-Pinheiro, Pedro (author), Silva-Santos, Rui (author), Dias, Paula C (author), Antunes, Luís (author), Lobo, Francisco (author), Oliveira, Jorge (author), Gonçalves, Céline S (author), Costa, Bruno M (author), Henrique, Rui (author), Jerónimo, Carmen (author)
Format: article
Language:eng
Published: 2019
Subjects:
Biomarkers, Tumor
Carcinoma, Renal Cell
Chromosomal Proteins, Non-Histone
Diagnosis, Differential
Early Detection of Cancer
Gene Expression Regulation, Neoplastic
Histone Demethylases
Histone-Lysine N-Methyltransferase
Kidney Neoplasms
Prognosis
Up-Regulation
Online Access:http://hdl.handle.net/10400.22/14164
Country:Portugal
Oai:oai:recipp.ipp.pt:10400.22/14164

Internet

http://hdl.handle.net/10400.22/14164

Similar Items